Yourgene’s Health gets approval to sell the chemotoxicity diagnostic assay in Australia
MANCHESTER: Yourgene Health, an international molecular diagnostics group, announced that its chemotoxicity diagnostics assay – Elucigene DPYD – which tests to identify cancer patients at risk of lethal side effects from chemotherapy, has been approved for sale in Australia by the Therapeutic Goods Administration (TGA) as an IVD (in vitro diagnostic). The TGA is the…